FY2025 EPS Estimates for Cognex Cut by Cantor Fitzgerald

Key Points

• Cantor Fitzgerald has lowered its FY2025 earnings per share estimate for Cognex Corporation from $0.66 to $0.62, reflecting a cautious outlook for the company's financial performance.
• Other analysts have varied opinions on Cognex, with Needham & Company raising its price target from $36.00 to $45.00 and maintaining a "buy" rating, while DA Davidson set a "neutral" rating at a $32.00 price target.
• Cognex recently reported a quarterly EPS of $0.25, exceeding expectations, and declared a dividend of $0.08 per share, which reflects a 0.8% yield.

Cognex Corporation (NASDAQ:CGNX - Free Report) - Stock analysts at Cantor Fitzgerald cut their FY2025 EPS estimates for Cognex in a research note issued to investors on Friday, August 1st. Cantor Fitzgerald analyst T. Jensen now forecasts that the scientific and technical instruments company will earn $0.62 per share for the year, down from their previous forecast of $0.66. The consensus estimate for Cognex's current full-year earnings is $0.61 per share. Cantor Fitzgerald also issued estimates for Cognex's FY2026 earnings at $0.95 EPS.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The company had revenue of $249.09 million during the quarter, compared to the consensus estimate of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The company's revenue for the quarter was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.23 earnings per share.

CGNX has been the topic of a number of other research reports. Needham & Company LLC increased their price objective on Cognex from $36.00 to $45.00 and gave the company a "buy" rating in a report on Thursday, July 31st. Cowen raised shares of Cognex from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Robert W. Baird boosted their target price on shares of Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a research note on Monday, June 16th. Melius upgraded shares of Cognex from a "hold" rating to a "buy" rating and set a $60.00 target price on the stock in a research report on Thursday, July 10th. Finally, TD Cowen upgraded shares of Cognex from a "hold" rating to a "buy" rating and set a $35.00 price objective for the company in a research report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $42.31.

Cognex Trading Up 0.6%

CGNX stock traded up $0.24 on Monday, hitting $41.13. 733,376 shares of the company's stock traded hands, compared to its average volume of 2,108,630. Cognex has a 1-year low of $22.67 and a 1-year high of $44.17. The stock has a market cap of $6.91 billion, a price-to-earnings ratio of 57.92 and a beta of 1.47. The stock has a fifty day moving average of $32.92 and a 200-day moving average of $31.90.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th will be given a dividend of $0.08 per share. The ex-dividend date of this dividend is Thursday, August 14th. This represents a $0.32 annualized dividend and a dividend yield of 0.8%. Cognex's payout ratio is 45.07%.

Hedge Funds Weigh In On Cognex

Hedge funds and other institutional investors have recently made changes to their positions in the company. Penserra Capital Management LLC acquired a new stake in Cognex during the 2nd quarter valued at $29,000. Geneos Wealth Management Inc. boosted its stake in shares of Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock valued at $27,000 after buying an additional 736 shares during the period. Farther Finance Advisors LLC grew its position in Cognex by 439.4% during the first quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company's stock worth $29,000 after buying an additional 791 shares in the last quarter. GAMMA Investing LLC increased its stake in Cognex by 155.3% during the 1st quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock worth $32,000 after acquiring an additional 646 shares during the period. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in Cognex by 231.9% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company's stock valued at $34,000 after acquiring an additional 756 shares in the last quarter. 88.12% of the stock is owned by institutional investors.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.